United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 881,300 | 790,600 | 669,200 | 656,000 | 745,900 |
| Marketable Securities | 904,900 | 814,500 | 746,700 | 581,600 | 467,100 |
| Receivables | 181,000 | 159,800 | 175,700 | 215,200 | 251,300 |
| Inventories | 96,900 | 96,200 | 101,000 | 101,000 | 102,700 |
| Other current assets | 75,700 | 81,400 | 75,400 | 54,900 | 57,200 |
| TOTAL | $2,139,800 | $1,942,500 | $1,768,000 | $1,608,700 | $1,624,200 |
| Non-Current Assets | |||||
| PPE Net | 709,300 | 701,200 | 699,700 | 665,200 | 626,100 |
| Investments And Advances | 420,700 | 411,300 | 442,600 | 595,900 | 578,300 |
| Other Non-Current Assets | 629,100 | 671,700 | 490,700 | 542,300 | 416,300 |
| TOTAL | $1,759,100 | $1,784,200 | $1,633,000 | $1,803,400 | $1,620,700 |
| Total Assets | $3,898,900 | $3,726,700 | $3,401,000 | $3,412,100 | $3,244,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 250,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 163,900 | 139,400 | 166,100 | 204,800 | 216,000 |
| Other current liabilities | 49,600 | 130,600 | 110,500 | 167,600 | 134,000 |
| TOTAL | $463,500 | $270,000 | $276,600 | $372,400 | $350,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 800,000 | 1,050,000 | 250,000 | 250,000 | 250,000 |
| Other Non-Current Liabilities | 77,000 | 87,700 | 85,800 | 96,900 | 79,300 |
| TOTAL | $877,000 | $1,137,700 | $335,800 | $346,900 | $329,300 |
| Total Liabilities | $1,340,500 | $1,407,700 | $612,400 | $719,300 | $679,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,850 | 43,811 | 43,722 | 43,587 | 43,563 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 3,140,200 | 2,935,100 | 3,434,800 | 3,369,500 | 3,263,000 |
| Other shareholders' equity | -5,200 | -5,400 | -8,100 | -22,400 | -22,100 |
| TOTAL | $2,558,400 | $2,319,000 | $2,788,600 | $2,692,800 | $2,565,600 |
| Total Liabilities And Equity | $3,898,900 | $3,726,700 | $3,401,000 | $3,412,100 | $3,244,900 |